Stryker completed the acquisition of MOLLI Surgical.

Stryker, a medical technologies firm, completed the acquisition of MOLLI Surgical, a company specializing in medical devices development. Financial terms were not disclosed. "The acquisition of MOLLI Surgical represents a significant step forward in our goal to provide surgeons with the most advanced tools to improve patient care. MOLLI Surgical complements our existing portfolio in the breast cancer space, which includes our SPY fluorescence imaging technology for lymphatic mapping and lighted retractors," Andrés Rosales, Stryker Endoscopy Business Vice President and General Manager.